Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
Clinical trial NCT04026009 · COMPLETED
Trial details
- NCT number
- NCT04026009
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-05
- Primary completion
- 2022-05-10
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.